CAVAC Extends Vaccine Supply Contract End Date to Dec. 7 After Test Report Delay

• CAVAC extended its SAT1 foot-and-mouth disease vaccine supply contract end date to Dec. 7, 2026, from Nov. 7, 2026.
• The revised deadline covers payment, reflecting delayed issuance of a test certificate by an overseas testing institution.
• The Public Procurement Service contract totals KRW 5.81 billion, equivalent to 11.85% of 2025 revenue.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CAVAC - Choong Ang Vaccine Laboratory Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261106900485), on November 06, 2026, and is solely responsible for the information contained therein.